1. Home
  2. URGN vs NRDS Comparison

URGN vs NRDS Comparison

Compare URGN & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

HOLD

Current Price

$19.24

Market Cap

922.1M

Sector

Health Care

ML Signal

HOLD

Logo NerdWallet Inc.

NRDS

NerdWallet Inc.

HOLD

Current Price

$11.40

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
URGN
NRDS
Founded
2004
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
922.1M
1.0B
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
URGN
NRDS
Price
$19.24
$11.40
Analyst Decision
Strong Buy
Buy
Analyst Count
7
6
Target Price
$29.29
$15.67
AVG Volume (30 Days)
697.0K
1.2M
Earning Date
06-10-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
68.42
EPS
N/A
0.64
Revenue
$1,128,000.00
$836,600,000.00
Revenue This Year
$119.37
$7.55
Revenue Next Year
$64.79
$8.31
P/E Ratio
N/A
$17.34
Revenue Growth
N/A
21.67
52 Week Low
$3.42
$7.55
52 Week High
$30.00
$16.24

Technical Indicators

Market Signals
Indicator
URGN
NRDS
Relative Strength Index (RSI) 41.99 54.00
Support Level $18.65 $10.25
Resistance Level $20.44 $11.35
Average True Range (ATR) 1.59 0.66
MACD -0.13 0.28
Stochastic Oscillator 32.02 94.78

Price Performance

Historical Comparison
URGN
NRDS

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.

About NRDS NerdWallet Inc.

Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.

Share on Social Networks: